echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature: Seeing through the "trick" of cancer cells brings new hope to patients with colorectal cancer

    Nature: Seeing through the "trick" of cancer cells brings new hope to patients with colorectal cancer

    • Last Update: 2021-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Colon cancer is a malignant tumor of the digestive tract that occurs in the colon of the human body, mostly in the age of 40-50


    Recently, the top academic journal "Nature" published three consecutive heavy articles that debunked the "trick" of cancer cells and provided new prevention strategies for people at high risk of colon cancer


    As we all know, stem cells are a type of cells with infinite or immortal self-renewal ability that can produce at least one type of highly differentiated progeny cells.


    The adenomatous polyposis colon (APC) disease gene in stem cells, as a tumor suppressor gene for colorectal cancer, is the most common site of germline and somatic mutations


    In recent years, with the advancement of technologies such as deep-targeted DNA sequencing, researchers have noticed that cancer-related mutant genes have already been latent in normal human tissues


    Of course, the research process of researchers does not stop here


    Excitingly, the experiment found the key vector of Apc mutation, "NOTUM gene".


    In order to further study the mechanism of the interaction between normal and malignant stem cells, researchers at the University of Amsterdam Medical Center in the Netherlands built mouse and human bowel cancer models mediated by Apc gene inactivation and found that APC-mediated β-catenin is one This kind of gene expression regulator that helps maintain the state of intestinal stem cells will actively inhibit the growth of neighboring cells and even induce the apoptosis of wild-type intestinal stem cells


    Not only that, cancer stem cells carrying Apc mutations have a stronger competitive advantage compared to normal stem cells.


    So far, the focus of medical research in the field of cancer has been on the promotion of immune system-mediated defenses


    Note: The original text has been deleted

    Reference materials:

    [1]https://#citeas

    [2]https://#citeas

    [3]https://#ref-CR1

    [4]https://

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.